To investigate the possibility of transmission of CTX-M-producing Escherichia coli isolates among humans and animals, we compared CTX-M-producing E. coli isolates showing the same genotype from humans and dogs in Korea. Sixteen CTX-M-producing E. coli isolates from animals were selected and their genotypes were identified using MLST. Among clinical CTX-M-producing E. coli isolates from humans, which have been identified in previous studies, 12 isolates showing the same STs with those of E. coli isolates from animals were selected. For these 28 CTX-M-producing E. coli isolates, identification of bla CTX-M genes and their genetic environments, antimicrobial susceptibility testing, extended MLST, and PFGE were performed. Some CTX-M-producing E. coli isolates from humans showed the same genotypes, such as ST10, ST38, ST58, and ST95, but different CTX-M enzymes and PFGE patterns. Thus, it can be concluded that dissemination of ESBL-producing E. coli isolates between humans and animals is rare so far.
INTRODUCTION
Escherichia coli is the one of the most common pathogens of bacterial infections worldwide. In particular, infections by extended spectrum β-lactamase (ESBL)-producing E. coli isolates have recently increased both in humans and animals (1) . Among ESBLs, the global spread of CTX-M-producing E. coli isolates in humans has been reported, and has been termed a 'CTX-M pandemic' (2) .
Recently, there has been a rapid spread of the CTX-M-15-producing ST131 clone of E. coli (3) . Since the first detection of an ESBL-producing E. coli isolate from a laboratory dog in Japan in 1998, a variety of ESBLs, including CTX-M-type ESBLs, have been isolated from various animals (4) . As in humans, highly virulent CTX-M-15-producing ST131 isolates were also reported mainly in European countries (5) . The dissemination of CTX-Mtype ESBLs among E. coli isolates may be due to horizontal transfer of IncFII-type plasmid as well as clonal expansion (5~7).
E. coli is a commensal bacterium in animals such as poultry and cattle, and food from animal origins can be contaminated with E. coli (1) . Since the late 1990s, ESBLproducing E. coli isolates have been found in retail meat and production animals worldwide (1) . Several recent studies 44 comparison among CTX-M-producing E. coli isolates from humans and animals was not performed.
To discern the possible transmission of CTX-Mproducing E. coli isolates among humans and animals, we compared CTX-M-producing E. coli isolates showing the same STs from humans and animals in Korea through the use of extended MLST and other techniques.
MATERIALS AND METHODS

Bacterial strains
Sixteen E. coli isolates from intestinal samples of animals taken during [2004] [2005] [2006] [2007] [2008] in Korea were included in this study. All of the isolates produced CTX-M-type ESBLs (9).
An additional 12 E. coli isolates showing the same sequence types (STs) of those animals were selected among 88 CTX-M-producing E. coli isolates from patients with bacteremia in a Korean hospital (10) .
Characterization of β-lactamase-encoding genes β-lactamase genes, including bla TEM , bla SHV , and bla CTX-M , were detected by gene amplification and sequencing using specific primers as described previously (11~13).
In vitro antimicrobial susceptibility testing
Minimum inhibitory concentrations (MICs) of antimicrobial agents were determined by a broth microdilution method according to Clinical and Laboratory Standards Institute (CLSI) guideline (14) . Ten antimicrobial agents were tested: amikacin, ampicillin, aztreonam, cefotaxime, ceftazidime, ciprofloxacin, gentamicin, imipenem, piperacillin /tazobactam, and trimethoprim/sulfamethoxazole. The results were interpreted based on susceptibility interpretive criteria established in the CLSI standard M100-S21 (14, 15) .
MLST genotyping and pulsed-field gel electrophoresis
MLST was performed using the protocols described at the website (http://mlst.ucc.ie/mlst/dbs/Senterica/documents/ primersEnterica_html) (16) (PFGE) analysis was used as previously described (18) .
Genetic environments of bla CTX-M genes
PCR mapping and sequencing were performed to investigate the genetic environment of the bla CTX-M genes using previously described primers (19, 20) . Sequences previously reported to be associated with the CTX-M group genes such as tnpA ISEcp1, ISEcp1, tnpA IS26, IS26, and ORF 513 were employed to investigate regions upstream of the bla CTX-M genes. bla CTX-M forward primer and reverse primers for ORF477, IS903, and tnpA IS903 were used to characterize downstream segments of the bla CTX-M genes.
All the positive PCR products obtained were subjected to direct sequencing on both strands and the resulting nucleotide sequences were analyzed.
RESULTS
β-lactamase-encoding genes of E. coli isolates from animals
Among 16 CTX-M-producing E. coli isolates from animals, most (13 isolates) produced CTX-M-9 group ESBLs and only three were positive for CTX-M-group 1 ( Table 1) . Eight of the E. coli isolates from animals produced CTX-M-14 enzymes, and three CTX-M-24-producing isolates were found. Among the CTX-M-1 group, CTX-M-3, CTX-M-15, and CTX-M-55 were found in each one isolate. While TEM-1 β-lactamase was found in seven isolates, SHV-type β-lactamase was not found in any.
Results of MLST and antibiotic susceptibility testing of E. coli isolates from animals
Among 16 CTX-M-producing E. coli isolates from animals, 13 different STs were identified in MLST analysis.
Only ST457 and ST327 were identified in multiple isolates: ST457 were found in two CTX-M-14-produing isolates and one CTX-M-27-producing isolates, and ST327 was found both in CTX-M-14-and CTX-M-65-producing isolate. All 16 isolates were resistant to ampicillin, cefotaxime, and piperacillin/tazobactam, and all but one was resistant to aztreonam. Five, seven, eight, and 12 isolates were resistant to ceftazidime, gentamicin, ciprofloxacin, and trimethoprim /sulfamethoxazole, respectively. Only two isolates were resistant to amikacin, and no isolates were resistant to imipenem. One isolate (05-D-37) showing ST2930 was non susceptible to all antimicrobial agents except imipenem.
Comparisons of β-lactamase-encoding genes and antibiotic susceptibility in E. coli isolates from humans and animals
In our previous study (10) , 12 E. coli isolates from humans were found which showed the same STs as those from animals: ST10, ST38, ST58, and ST95 (Table 2 ). ST10 
and ST95 were found only in E. coli isolates producing CTX-M-14 (CTX-M-9 group), and ST58 was identified only in isolates producing CTX-M-3 (CTX-M-1 group).
ST38 was found both in CTX-M-14-and CTX-M-15-producing E. coli isolates. The 12 E. coli isolates from
humans produced TEM-1 β-lactamase, but no isolates produced SHV-type β-lactamase. Antimicrobial resistance profiles of E. coli isolates from humans were similar to those of E. coli isolates from animals. However, the rate of ceftazidime resistance was higher in E. coli isolates from humans (7/12 isolates), and the piperacillin/tazobactam resistance rate was lower in isolates from humans (7/12 isolates). As in E. coli isolates from animals, no imipenemresistant isolates were found in humans. Two isolate (K01-08133 and K01-11045) was non susceptible to all antimicrobial agents except imipenem.
Results of clonality studies in E. coli isolates from human and animals
E. coli isolates with the same ST showed the same or similar genotypes in EcMLST ( (Table 3) . Three ST10, ST38, and ST58 E. coli isolates from animals showed different PFGE patterns from ST10, ST38, and ST58 E. coli isolates from human, respectively (Fig. 1) .
Analysis of the regions surrounding bla CTX-M genes
Two ST10 isolates from dogs and humans showed different genetic environments, and two ST58 isolates from pigs and humans showed the same genetic environment, which is labeled C in Table 3 . Four ST38 E. coli isolates from human showed the same genetic environment (labeled B) as an ST38 E. coli isolate from dog (E-121), while one (B0608-154) did not (Table 3) .
DISCUSSION
A recent study showed an extreme low-level rate of 
